Monosialoganglioside-Containing Nanoliposomes Protect Against Acute and Chronic Ischemic Stroke Injury

Saif Ahmad1, Takuma Maeda1, Jessica Contreras1

  • 1Department of Translational Neuroscience/Neurosurgery, Barrow Neurological Institute/St. Joseph's Hospital and Medical Center Phoenix AZ USA.

Summary

Nanoliposomes (NLGM1) administered after ischemic stroke in mice reduced brain infarct size and improved motor and behavioral functions. This suggests NLGM1 is a promising neuroprotective agent for stroke treatment.